Anti-nicotine abuse vaccines in the pipeline: An update

Expert Opinion on Investigational Drugs

Volumn 17, Issue 5, 2008, Pages 691-696

  Cerny, Erich H ^a   Cerny, Thomas ^b  

^a Chilka Ltd   (Switzerland)

^b CANTONAL HOSPITAL ST GALLEN   (Switzerland)

Author keywords

Anti nicotine vaccine; Bupropion; Celtic Pharma; Clinical trial; Commercialization; Cytos AG; Nabi; Pipeline; Varenicline

Indexed keywords

AMFEBUTAMONE; ANTIBODY; NIC 002; NICOTINE VACCINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; PLACEBO; TA NIC; VARENICLINE; NICOTINE; RECOMBINANT VACCINE;

ADJUVANT THERAPY; ANTIBODY PRODUCTION; BEHAVIOR THERAPY; BODY TEMPERATURE; CLINICAL PROTOCOL; CLINICAL TRIAL; COLD; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; FEVER; FLU LIKE SYNDROME; HUMAN; IMMUNOGENICITY; MYALGIA; NAUSEA; PSYCHOTHERAPY; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; SMOKING CESSATION PROGRAM; TOBACCO DEPENDENCE; UNSPECIFIED SIDE EFFECT; ACTIVE IMMUNIZATION; IMMUNOLOGY; METABOLISM; METHODOLOGY; SMOKING CESSATION;

ANTIBODY FORMATION; CLINICAL TRIALS AS TOPIC; HUMANS; IMMUNOTHERAPY, ACTIVE; NICOTINE; RECEPTORS, NICOTINIC; SMOKING CESSATION; TOBACCO USE DISORDER; VACCINES, SYNTHETIC;

EID: 44449086535     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.17.5.691     Document Type: Review

References (33)

1. Stead L, Perera F, Bullen C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2008;1:CD000146
2. Le Foll B, George TP. Treatment of tobacco dependence: integrating recent progress into practice. Can Med Assoc J 2007;177(11):1373-80
3. Tonstad S, Tonnesen P, Hajek P, et al. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. J Am Med Assoc 2006;296(1):64-71
4. Fava M, Rush AJ, Thase ME, et al. 15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL. Prim Care Companion J Clin Psychiatry 2005;7(3):106-13
5. Wu P Wilson K, Dimoulas P, Mills EJ, et al. Effectiveness of smoking cessation therapies: a systematic review and meta-analysis. BMC Pub Health 2006;6:300
6. Jorenby DE, Hays JT, Rigotti NA, et al. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. J Am Med Assoc 2006;296(1):56-63
7. Schnoll RA, Patterson F, Lerman C. Treating tobacco dependence in women. J Womens Health (Larchmt) 2007;16(8):1211-8
8. Cytos Biotechnology AG. Company website. Schlieren: Cytos Biotechnology AG. Available from: www.cytos.ch [Last accessed December 2007]
9. Nabi Biopharmaceuticals. Company website. Rockville, MD: Nabi Biopharmaceuticals. Available from: www.nabi.com [Last accessed December 2007]
10. Celtic Pharma. Company website. Hamilton, Bermuda: Celtic Pharma. Available from: www.celticpharma.com [Last accessed December 2007)
11. Maurer P, Bachmann MF. Vaccination against nicotine: an emerging therapy fbr tobacco dependence. Expert Opin Investig Drugs 2007;16(11):1775-83
12. Heading CE. Drug evaluation: CYT-002-NicQb, a therapeutic vaccine for the treatment of nicotine addiction. Curr Opin Investig Drugs 2007;8(1):71-7
13. Dyer MR, Renner WA, Bachmann MF. A second vaccine revolution for the new epidemics of the 21st century. Drug Discov Today 2006;11(21-22):1028-33
14. Maurer P, Bachmann MF. Therapeutic vaccines for nicotine dependence. Curr Opin Mol Ther 2006;8(1):11-6
15. Maurer P, Jennings GT, Willers J, et al. A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity. Eur J Immunol 2005;35(7):2031-40
16. Cerny T. Anti-nicotine vaccination: where are we? Recent Results Cancer Res 2005;166:167-75
17. No authors listed. Trial watch. Xenova's TA-NIC vaccine shows promise. Expert Rev Vaccines 2004;3(4):386
18. Goniewicz, ML, Koszowski B, Czogala J, Zymelka A, et al. New prospects of nicotine dependence treatment: vaccines. Przegl Lek 2006;63(10):1114-8
19. Heading CE. TA-CD: Xenova. IDrugs 2002;5(11):1070-4
20. Kosten TR, Rosen M, Bond J, et al. Human therapeutic cocaine vaccine: safety and immunogenicity. Vaccine 2002;20(7-8):1196-204
21. Martell BA, Mitchell E, Poling J, et al. Vaccine pharmacotherapy for the treatment of cocaine dependence. Biol Psychiatry 2005;58(2):158-64
22. Heading CE. NicVAX: Nabi Biopharmaceuticals. IDrugs 2003;6(12):1178-81
23. Hatsukami DK, Rennard S, Jorenby D, et al. Safety and immunogenicity of a nicotine conjugate vaccine in current smokers. Clin Pharmacol Ther 2005;78(5):456-67
24. Sanderson SD, Cheruku SR, Padmanilayam MP, et al. Immunization to nicotine with a peptide-based vaccine composed of a conformationally biased agonist of C5a as a molecular adjuvant. Int Immunopharmacol 2003;3(1):137-46
25. Carrera MR, Ashley JA, Hoffman TZ, et al. Investigations using immunization to attenuate the psychoactive effects of nicotine. Bioorg Med Chem 2004;12(3):563-70
26. Meijler MM, Matsushita M, Altobell LJ, 3rd, et al. A new strategy for improved nicotine vaccines using conformationally constrained haptens. J Am Chem Soc 2003;125(24):7164-5
27. Dickerson TJ, Yamamoto N, Janda KD. Antibody-catalyzed oxidative degradation of nicotine using riboflavin. Bioorg Med Chem 2004;12(18):4981-7
28. de Villiers SH, Lindblom N, Kalayanov G, et al. Active immunization against nicotine suppresses nicotine-induced dopamine release in the rat nucleus accumbens shell. Respiration 2002;69(3):247-53
29. Lindblom N, de Villiers SH, Kalayanov G, et al. Active immunization against nicotine prevents reinstatement of nicotine-seeking behavior in rats. Respiration 2002;69(3):254-60
30. Cho CH, Purohit V. Alcohol tobacco and cancer. Karger, Basel/New York; 2006
31. Hasman A, Holm S. Nicotine conjugate vaccine: is there a right to a smoking future? J Med Ethics 2004;30(4):344-45
32. Cerny T, Cerny EH: Reply to: Hasman A, Holm S. Nicotine conjugate vaccine: is there a right to a smoking future? J Med Ethics 2005;31(9):558
33. Cerny EH, Levy R, Mauel J, et al. Preclinical development of a vaccine 'against smoking'. Onkologie 2002;25(5):406-11